List view / Grid view
29 September 2014 | By SIGMOID PHARMA LIMITED
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
26 September 2014 | By EATRIS
EATRIS has signed a formal framework agreement with the Roche Partnering Extending Innovation Network (EIN) program...
26 September 2014 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of the pharmaceutical development company, InnoPharma, Inc., following receipt of United States (U.S.) regulatory approval from all government authorities required by the agreement and other closing conditions...
25 September 2014 | By Ecolab
Recent guidelines aimed at raising standards of contamination control in the pharmaceutical industry mean organisations need to assess their current practices...
25 September 2014 | By SGS Life Science Services
SGS Life Science Services announced the the completion of its fifth North American Life Science Services laboratory, in Carson, California...
25 September 2014 | By TXCELL
TxCell reports its financial results for the first half of 2014...
25 September 2014 | By Horizon Discovery
Agreement covers development of molecular reference standards for companion diagnostics...
25 September 2014 | By Probiodrug
Probiodrug AG announces its intention to raise new funds through an Initial Public Offering and listing on Euronext Amsterdam...
23 September 2014 | By nLife
The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development...
23 September 2014 | By The Institute of Cancer Research
Even long stretches of DNA that contain no genes at all can affect the risk of breast cancer, by physically interacting with genes elsewhere, a new study reports...
23 September 2014 | By Horizon Discovery
Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...
22 September 2014 | By Children’s Cancer Institute and Abcam plc
Compounds allow further exploration of MRP4 function and have potential in cancer therapeutic development...
19 September 2014 | By Sanofi
Sanofi and MyoKardia, Inc. announced a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most common forms of heart muscle disease...
19 September 2014 | By Boehringer Ingelheim
Boehringer Ingelheim and CureVac, leader in mRNA (messenger ribonucleic acid)-based drug development, jointly announce an exclusive global license and development collaboration...
16 September 2014 | By Andrew Lloyd & Associates
Curie-Cancer and Inventiva announce the launch of the Epicure project, which has just received financial backing from France’s national research agency, the ANR...
